Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy

• Main Authors: Lu-Qi Cao (Author), Haidong Sun (Author), Yuhao Xie (Author), Harsh Patel (Author), Letao Bo (Author), Hanli Lin (Author), Zhe-Sheng Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Breast cancer, a complex and varied disease, has four distinct subtypes based on estrogen receptor and human epidermal growth factor receptor 2 (HER2) levels, among which a significant subtype known as HR+/HER2-breast cancer that has spurred numerous research. The prevalence of breast cancer and bre...